Krause M - Search Results

1

Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity.

Schwarz FM, Schniewind I, Besso MJ, Lange S, Linge A, Patil SG, Löck S, Klusa D, Dietrich A, Voss-Böhme A, Nowrouzi A, Krause M, Dubrovska A, Kurth I, Peitzsch C. Schwarz FM, et al. Among authors: krause m. Mol Cancer Res. 2022 May 4;20(5):794-809. doi: 10.1158/1541-7786.MCR-21-0806. Mol Cancer Res. 2022. PMID: 35135863 Free article.

2

Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.

Yaromina A, Krause M, Thames H, Rosner A, Krause M, Hessel F, Grenman R, Zips D, Baumann M. Yaromina A, et al. Among authors: krause m. Radiother Oncol. 2007 Jun;83(3):304-10. doi: 10.1016/j.radonc.2007.04.020. Epub 2007 May 22. Radiother Oncol. 2007. PMID: 17517444

3

Exploring the role of cancer stem cells in radioresistance.

Baumann M, Krause M, Hill R. Baumann M, et al. Among authors: krause m. Nat Rev Cancer. 2008 Jul;8(7):545-54. doi: 10.1038/nrc2419. Epub 2008 May 30. Nat Rev Cancer. 2008. PMID: 18511937 Review.

4

Cancer stem cells and radiotherapy.

Baumann M, Krause M, Thames H, Trott K, Zips D. Baumann M, et al. Among authors: krause m. Int J Radiat Biol. 2009 May;85(5):391-402. doi: 10.1080/09553000902836404. Int J Radiat Biol. 2009. PMID: 19382020 Review.

5

Three-dimensional cell growth confers radioresistance by chromatin density modification.

Storch K, Eke I, Borgmann K, Krause M, Richter C, Becker K, Schröck E, Cordes N. Storch K, et al. Among authors: krause m. Cancer Res. 2010 May 15;70(10):3925-34. doi: 10.1158/0008-5472.CAN-09-3848. Epub 2010 May 4. Cancer Res. 2010. PMID: 20442295

6

CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy.

Baumann M, Krause M. Baumann M, et al. Among authors: krause m. Clin Cancer Res. 2010 Nov 1;16(21):5091-3. doi: 10.1158/1078-0432.CCR-10-2244. Epub 2010 Sep 22. Clin Cancer Res. 2010. PMID: 20861165

7

Cancer stem cells: targets and potential biomarkers for radiotherapy.

Krause M, Yaromina A, Eicheler W, Koch U, Baumann M. Krause M, et al. Clin Cancer Res. 2011 Dec 1;17(23):7224-9. doi: 10.1158/1078-0432.CCR-10-2639. Epub 2011 Oct 5. Clin Cancer Res. 2011. PMID: 21976536

8

Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis.

Eke I, Storch K, Krause M, Cordes N. Eke I, et al. Among authors: krause m. Cancer Res. 2013 Oct 1;73(19):5869-79. doi: 10.1158/0008-5472.CAN-13-0344. Epub 2013 Aug 15. Cancer Res. 2013. PMID: 23950208

9

Concept for individualized patient allocation: ReCompare--remote comparison of particle and photon treatment plans.

Lühr A, Löck S, Roth K, Helmbrecht S, Jakobi A, Petersen JB, Just U, Krause M, Enghardt W, Baumann M. Lühr A, et al. Among authors: krause m. Radiat Oncol. 2014 Feb 18;9:59. doi: 10.1186/1748-717X-9-59. Radiat Oncol. 2014. PMID: 24548333 Free PMC article.

10

EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.

Wang M, Kern AM, Hülskötter M, Greninger P, Singh A, Pan Y, Chowdhury D, Krause M, Baumann M, Benes CH, Efstathiou JA, Settleman J, Willers H. Wang M, et al. Among authors: krause m. Cancer Res. 2014 May 15;74(10):2825-34. doi: 10.1158/0008-5472.CAN-13-3157. Epub 2014 Mar 19. Cancer Res. 2014. PMID: 24648348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,170 results

Search Page

Filters